879 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B N/A
Article Searches
Roche's Tecentriq Combo Gets EU Nod for Difficult Lung Cancer http://www.zacks.com/stock/news/505009/roches-tecentriq-combo-gets-eu-nod-for-difficult-lung-cancer?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-505009 Sep 06, 2019 - The latest EU nod makes Roche's (RHHBY) immuno-oncology drug -- Tecentriq -- the first and only cancer immunotherapy approved for the initial treatment of ES-SCLC in Europe.
AstraZeneca's Tagrisso Gets Nod in China for First-Line NSCLC http://www.zacks.com/stock/news/503575/astrazenecas-tagrisso-gets-nod-in-china-for-first-line-nsclc?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-503575 Sep 05, 2019 - AstraZeneca's (AZN) Tagrisso gets a marketing approval in China for the first-line treatment of advanced or metastatic non-small cell lung cancer in patients with tumors having EGFR mutations.
Is the FDA Out to Get This $2.9 Billion Diabetes Drug Class? https://www.fool.com/investing/2019/09/05/is-the-fda-out-to-get-this-29-billion-diabetes-dru.aspx?source=iedfolrf0000001 Sep 05, 2019 - It’s rejected a pair of drugs in the last six months.
Endo Gains FDA Nod for Orfadin Generic to Treat Rare Disease http://www.zacks.com/stock/news/503280/endo-gains-fda-nod-for-orfadin-generic-to-treat-rare-disease?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-503280 Sep 05, 2019 - Endo (ENDP) receives an FDA approval for the generic equivalent of Swedish Orphan Biovitrum's Orfadin.
Merck's Keytruda Combination Gets EC Nod for Kidney Cancer http://www.zacks.com/stock/news/503040/mercks-keytruda-combination-gets-ec-nod-for-kidney-cancer?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-503040 Sep 05, 2019 - Merck's (MRK) label expansion application for Keytruda in combination with Pfizer's Inlyta for the first-line treatment of renal cell carcinoma gets approval in Europe.
AbbVie Ends Rova-T Program as 3rd Lung Cancer Study Fails http://www.zacks.com/stock/news/495982/abbvie-ends-rova-t-program-as-3rd-lung-cancer-study-fails?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-495982 Aug 30, 2019 - IDMC recommends termination of AbbVie's (ABBV) late-stage study on its small cell lung cancer candidate, Rova-T. AbbVie discontinues development.
Busy Morning for Investors: Trade, Data, Earnings for PFE, MRK, COP & More http://www.zacks.com/stock/news/453588/busy-morning-for-investors-trade-data-earnings-for-pfe-mrk-cop-more?cid=CS-ZC-FT-ahead_of_wall_street-453588 Jul 30, 2019 - Another busy day awaits investors here in the middle of summer: U.S.-China trade talks resume, Personal Income & Spending data is out and Q2 earnings continue their torrent.
Are You Looking for a High-Growth Dividend Stock? Merck (MRK) Could Be a Great Choice http://www.zacks.com/stock/news/432705/are-you-looking-for-a-high-growth-dividend-stock-merck-mrk-could-be-a-great-choice?cid=CS-ZC-FT-432705 Jun 21, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Merck (MRK) have what it takes? Let's find out.
Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod http://www.zacks.com/stock/news/432688/pharma-stock-roundup-pfe-to-buy-arry-rhhby-mrk-azn-drugs-get-regulatory-nod?cid=CS-ZC-FT-432688 Jun 21, 2019 - Pfizer (PFE) announces definitive deal buy Array BioPharma. Merck (MRK), Roche (RHHBY) and AstraZeneca (AZN) win approvals for new drugs/line extensions.
Dow 30 Stock Roundup: Boeing's $6.5B Air Force Contract, Pfizer to Buy Array BioPharma http://www.zacks.com/stock/news/432790/dow-30-stock-roundup-boeings-%2465b-air-force-contract-pfizer-to-buy-array-biopharma?cid=CS-ZC-FT-432790 Jun 21, 2019 - The index enjoyed another week of strong gains after the Federal Reserve indicated that a rate cut would likely occur next month.

Pages: 1234567...88

<Page 2>